Possible influence of noradrenaline on beta-adrenergic and muscarinic cholinergic receptors in rat heart: effects of 6-hydroxydopa, isoproterenol, and desmethylimipramine.
D000818:Animals; D003891:Desipramine / Q000494:pharmacology; D004082:Dihydroalprenolol / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology*; D009955:Ornithine Decarboxylase / Q000378:metabolism; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*
D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; C001388:6-hydroxydopa; D004082:Dihydroalprenolol; D004295:Dihydroxyphenylalanine; D011813:Quinuclidinyl Benzilate; D009955:Ornithine Decarboxylase; D007545:Isoproterenol; D003891:Desipramine; D009638:Norepinephrine